| Neonatal infection: antibiotics for prevention and treatment | NG195 | | |
| Acne vulgaris: management | NG198 | | |
| Ovarian cancer: recognition and initial management | CG122 | | |
| Suspected cancer: recognition and referral | NG12 | | |
| Menopause: identification and management | NG23 | | |
| Fetal monitoring in labour | NG229 | | |
| Artificial intelligence (AI) technologies to help detect or characterise colorectal polyps | HTG773 | | |
| Pegzilarginase for treating arginase-1 deficiency in people 2 years and over | HST35 | | |
| Hypertension in adults: diagnosis and management | NG136 | | |
| Blood transfusion | NG24 | | |
| Type 2 diabetes in adults: management | NG28 | | |
| Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 | HST34 | | |
| Pulmonary artery pressure technologies for remote monitoring of chronic heart failure | HTG769 | | |
| Overweight and obesity management | NG246 | | |
| Child maltreatment: when to suspect maltreatment in under 18s | CG89 | | |
| Suspected sepsis in people aged 16 or over: recognition, assessment and early management | NG253 | | |
| Suspected sepsis in under 16s: recognition, diagnosis and early management | NG254 | | |
| Suspected sepsis in pregnant or recently pregnant people: recognition, diagnosis and early management | NG255 | | |
| Intrapartum care | NG235 | | |
| Rehabilitation for chronic neurological disorders including acquired brain injury | NG252 | | |
| Atopic eczema in under 12s: diagnosis and management | CG57 | | |
| Chronic heart failure in adults: diagnosis and management | NG106 | | |
| Pneumonia: diagnosis and management | NG250 | | |
| Bipolar disorder: assessment and management | CG185 | | |
| Suspected acute respiratory infection in over 16s: assessment at first presentation and initial management | NG237 | | |
| Caesarean birth | NG192 | | |
| Headaches in over 12s: diagnosis and management | CG150 | | |
| Abortion care | NG140 | | |
| Falls: assessment and prevention in older people and in people 50 and over at higher risk | NG249 | | |
| Leniolisib for treating activated phosphoinositide 3-kinase delta syndrome in people 12 years and over | HST33 | | |
| Early and locally advanced breast cancer: diagnosis and management | NG101 | | |
| Burosumab for treating X-linked hypophosphataemia in children and young people | HST8 | | |
| Olipudase alfa for treating acid sphingomyelinase deficiency (Niemann–Pick disease) type AB and type B | HST32 | | |
| Advanced breast cancer: diagnosis and treatment | CG81 | | |
| Epilepsies in children, young people and adults | NG217 | | |
| Gambling-related harms: identification, assessment and management | NG248 | | |
| Home-testing devices for diagnosing obstructive sleep apnoea hypopnoea syndrome | HTG735 | | |
| Asthma pathway (BTS, NICE, SIGN) | NG244 | | |
| Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN) | NG245 | | |
| Endometriosis: diagnosis and management | NG73 | | |
| Heart failure algorithms for remote monitoring in people with cardiac implantable electronic devices | HTG730 | | |
| Digital technologies for assessing attention deficit hyperactivity disorder (ADHD) | HTG729 | | |
| Acute kidney injury: prevention, detection and management | NG148 | | |
| Adrenal insufficiency: identification and management | NG243 | | |
| Diabetic retinopathy: management and monitoring | NG242 | | |
| CYP2C19 genotype testing to guide clopidogrel use after ischaemic stroke or transient ischaemic attack | HTG724 | | |
| Setmelanotide for treating obesity and hyperphagia in Bardet-Biedl syndrome | HST31 | | |
| Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer | HTG719 | | |
| Artificial intelligence (AI)-derived software to help clinical decision making in stroke | HTG708 | | |
| Twin and triplet pregnancy | NG137 | | |
| Ovarian cancer: identifying and managing familial and genetic risk | NG241 | | |
| Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management | NG240 | | |
| Lung cancer: diagnosis and management | NG122 | | |
| Vitamin B12 deficiency in over 16s: diagnosis and management | NG239 | | |
| Tuberculosis | NG33 | | |
| Devices for remote monitoring of Parkinson's disease | HTG657 | | |
| Sebelipase alfa for treating Wolman disease | HST30 | | |
| Cardiovascular disease: risk assessment and reduction, including lipid modification | NG238 | | |
| Velmanase alfa for treating alpha-mannosidosis | HST29 | | |
| Transient loss of consciousness ('blackouts') in over 16s | CG109 | | |
| Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer | CG164 | | |
| Jaundice in newborn babies under 28 days | CG98 | | |
| Stroke rehabilitation in adults | NG236 | | |
| Thyroid disease: assessment and management | NG145 | | |
| Urinary incontinence in neurological disease: assessment and management | CG148 | | |
| Suspected neurological conditions: recognition and referral | NG127 | | |
| Hearing loss in adults: assessment and management | NG98 | | |
| Birch bark extract for treating epidermolysis bullosa | HST28 | | |
| Cirrhosis in over 16s: assessment and management | NG50 | | |
| Spinal metastases and metastatic spinal cord compression | NG234 | | |
| Otitis media with effusion in under 12s | NG233 | | |
| Quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care | HTG690 | | |
| Ectopic pregnancy and miscarriage: diagnosis and initial management | NG126 | | |
| Venous thromboembolic diseases: diagnosis, management and thrombophilia testing | NG158 | | |
| Afamelanotide for treating erythropoietic protoporphyria | HST27 | | |
| Artificial intelligence (AI)-derived computer-aided detection (CAD) software for detecting and measuring lung nodules in CT scan images | HTG687 | | |
| Oesophago-gastric cancer: assessment and management in adults | NG83 | | |
| FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care | HTG682 | | |
| Transperineal biopsy for diagnosing prostate cancer | HTG680 | | |
| Automated ankle brachial pressure index measurement devices to detect peripheral arterial disease in people with leg ulcers | HTG677 | | |
| MRI fusion biopsy systems for diagnosing prostate cancer | HTG678 | | |
| Head injury: assessment and early management | NG232 | | |
| Diabetes (type 1 and type 2) in children and young people: diagnosis and management | NG18 | | |
| Metastatic malignant disease of unknown primary origin in adults: diagnosis and management | CG104 | | |
| Onasemnogene abeparvovec for treating spinal muscular atrophy | HST15 | | |
| Onasemnogene abeparvovec for treating presymptomatic spinal muscular atrophy | HST24 | | |
| Lumasiran for treating primary hyperoxaluria type 1 | HST25 | | |
| Eladocagene exuparvovec for treating aromatic L-amino acid decarboxylase deficiency | HST26 | | |
| Hypertension in pregnancy: diagnosis and management | NG133 | | |
| Asfotase alfa for treating paediatric-onset hypophosphatasia | HST23 | | |
| Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene | HST22 | | |
| Barrett's oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and management | NG231 | | |
| Delirium: prevention, diagnosis and management in hospital and long-term care | CG103 | | |
| MRI-based technologies for assessing non-alcoholic fatty liver disease | HTG655 | | |
| Hip fracture: management | CG124 | | |
| Thyroid cancer: assessment and management | NG230 | | |
| Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management | NG228 | | |
| Fractures (complex): assessment and management | NG37 | | |
| Osteoarthritis in over 16s: diagnosis and management | NG226 | | |
| Colorectal cancer prevention: colonoscopic surveillance in adults with ulcerative colitis, Crohn's disease or adenomas | CG118 | | |
| Self-harm: assessment, management and preventing recurrence | NG225 | | |
| Type 1 diabetes in adults: diagnosis and management | NG17 | | |
| Urinary tract infection in under 16s: diagnosis and management | NG224 | | |
| Melanoma: assessment and management | NG14 | | |
| PLGF-based testing to help diagnose suspected preterm pre-eclampsia | HTG630 | | |
| Setmelanotide for treating obesity caused by LEPR or POMC deficiency | HST21 | | |
| Depression in adults: treatment and management | NG222 | | |
| Multiple sclerosis in adults: management | NG220 | | |
| Preterm labour and birth | NG25 | | |
| Gout: diagnosis and management | NG219 | | |
| Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and over | HST20 | | |
| Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults | NG215 | | |
| Elosulfase alfa for treating mucopolysaccharidosis type 4A | HST19 | | |
| Stroke and transient ischaemic attack in over 16s: diagnosis and initial management | NG128 | | |
| Freelite assays for diagnosing multiple myeloma and related conditions (terminated assessment) | HTG619 | | |
| Atidarsagene autotemcel for treating metachromatic leukodystrophy | HST18 | | |
| PredictSURE IBD and IBDX to guide treatment of Crohn's disease | HTG610 | | |
| EarlyCDT Lung for assessing risk of lung cancer in solid lung nodules | HTG611 | | |
| Odevixibat for treating progressive familial intrahepatic cholestasis | HST17 | | |
| Glaucoma: diagnosis and management | NG81 | | |
| Rehabilitation after traumatic injury | NG211 | | |
| Colorectal cancer | NG151 | | |
| Prostate cancer: diagnosis and management | NG131 | | |
| Pelvic floor dysfunction: prevention and non-surgical management | NG210 | | |
| Fever in under 5s: assessment and initial management | NG143 | | |
| Chronic kidney disease: assessment and management | NG203 | | |
| Givosiran for treating acute hepatic porphyria | HST16 | | |
| Acute heart failure: diagnosis and management | CG187 | | |
| Heart valve disease presenting in adults: investigation and management | NG208 | | |
| SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea | HTG598 | | |
| Inducing labour | NG207 | | |
| Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management | NG206 | | |
| Babies, children and young people's experience of healthcare | NG204 | | |
| Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s | NG202 | | |
| Antenatal care | NG201 | | |
| Bronchiolitis in children: diagnosis and management | NG9 | | |
| Atrial fibrillation: diagnosis and management | NG196 | | |
| Patient experience in adult NHS services: improving the experience of care for people using adult NHS services | CG138 | | |
| Shared decision making | NG197 | | |
| Autism spectrum disorder in adults: diagnosis and management | CG142 | | |
| Autism spectrum disorder in under 19s: support and management | CG170 | | |
| Heavy menstrual bleeding: assessment and management | NG88 | | |
| Postnatal care | NG194 | | |
| Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain | NG193 | | |
| Cannabis-based medicinal products | NG144 | | |
| QAngio XA 3D QFR and CAAS vFFR imaging software for assessing coronary stenosis during invasive coronary angiography | HTG571 | | |
| Metreleptin for treating lipodystrophy | HST14 | | |
| Brain tumours (primary) and brain metastases in over 16s | NG99 | | |
| Pancreatitis | NG104 | | |
| Diabetes in pregnancy: management from preconception to the postnatal period | NG3 | | |
| Eating disorders: recognition and treatment | NG69 | | |
| Peripheral arterial disease: diagnosis and management | CG147 | | |
| Low back pain and sciatica in over 16s: assessment and management | NG59 | | |
| Acute coronary syndromes | NG185 | | |
| Testing strategies for Lynch syndrome in people with endometrial cancer | HTG557 | | |
| Volanesorsen for treating familial chylomicronaemia syndrome | HST13 | | |
| Rheumatoid arthritis in adults: management | NG100 | | |
| Neuropathic pain in adults: pharmacological management in non-specialist settings | CG173 | | |
| Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke | HTG553 | | |
| High-sensitivity troponin tests for the early rule out of NSTEMI | HTG552 | | |
| Anaphylaxis: assessment and referral after emergency treatment | CG134 | | |
| Perioperative care in adults | NG180 | | |
| Surgical site infections: prevention and treatment | NG125 | | |
| Rehabilitation for adults with complex psychosis | NG181 | | |
| Tests to help assess risk of acute kidney injury for people being considered for critical care admission (ARCHITECT and Alinity i Urine NGAL assays, BioPorto NGAL test and NephroCheck test) | HTG544 | | |
| Generalised anxiety disorder and panic disorder in adults: management | CG113 | | |
| Intravenous fluid therapy in children and young people in hospital | NG29 | | |
| Joint replacement (primary): hip, knee and shoulder | NG157 | | |
| Abdominal aortic aneurysm: diagnosis and management | NG156 | | |
| Tinnitus: assessment and management | NG155 | | |
| Neonatal parenteral nutrition | NG154 | | |
| SepsiTest assay for rapidly identifying bloodstream bacteria and fungi | HTG400 | | |
| Antenatal and postnatal mental health: clinical management and service guidance | CG192 | | |
| Diverticular disease: diagnosis and management | NG147 | | |
| Rapid tests for group A streptococcal infections in people with a sore throat | HTG531 | | |
| Point-of-care creatinine devices to assess kidney function before CT imaging with intravenous contrast | HTG530 | | |
| Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management | CG184 | | |
| End of life care for adults: service delivery | NG142 | | |
| Diabetic foot problems: prevention and management | NG19 | | |
| Gastro-oesophageal reflux disease in children and young people: diagnosis and management | NG1 | | |
| Voretigene neparvovec for treating inherited retinal dystrophies caused by RPE65 gene mutations | HST11 | | |
| Familial hypercholesterolaemia: identification and management | CG71 | | |
| Attention deficit hyperactivity disorder: diagnosis and management | NG87 | | |
| Patisiran for treating hereditary transthyretin amyloidosis | HST10 | | |
| Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism | NG89 | | |
| Chronic obstructive pulmonary disease in over 16s: diagnosis and management | NG115 | | |
| End of life care for infants, children and young people with life-limiting conditions: planning and management | NG61 | | |
| Motor neurone disease: assessment and management | NG42 | | |
| Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis | HTG521 | | |
| Long-acting reversible contraception | CG30 | | |
| Depression in children and young people: identification and management | NG134 | | |
| Urinary incontinence and pelvic organ prolapse in women: management | NG123 | | |
| Hyperparathyroidism (primary): diagnosis, assessment and initial management | NG132 | | |
| Lead-I ECG devices for detecting symptomatic atrial fibrillation using single time point testing in primary care | HTG508 | | |
| Crohn's disease: management | NG129 | | |
| Ulcerative colitis: management | NG130 | | |
| Intrapartum care for women with existing medical conditions or obstetric complications and their babies | NG121 | | |
| Specialist neonatal respiratory care for babies born preterm | NG124 | | |
| Cerebral palsy in adults | NG119 | | |
| Renal and ureteric stones: assessment and management | NG118 | | |
| Post-traumatic stress disorder | NG116 | | |
| Myeloma: diagnosis and management | NG35 | | |
| Lyme disease | NG95 | | |
| Renal replacement therapy and conservative management | NG107 | | |
| Biomarker tests to help diagnose preterm labour in women with intact membranes | HTG476 | | |
| Dementia: assessment, management and support for people living with dementia and their carers | NG97 | | |
| Cancer of the upper aerodigestive tract: assessment and management in people aged 16 or over | NG36 | | |
| Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan I | HTG467 | | |
| Emergency and acute medical care in over 16s: service delivery and organisation | NG94 | | |
| Pancreatic cancer in adults: diagnosis and management | NG85 | | |
| Strimvelis for treating adenosine deaminase deficiency–severe combined immunodeficiency | HST7 | | |
| Age-related macular degeneration | NG82 | | |
| Autism spectrum disorder in under 19s: recognition, referral and diagnosis | CG128 | | |
| Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system) | HTG353 | | |
| Tests in secondary care to identify people at high risk of ovarian cancer | HTG453 | | |
| Cataracts in adults: management | NG77 | | |
| Cystic fibrosis: diagnosis and management | NG78 | | |
| Hepatitis B (chronic): diagnosis and management | CG165 | | |
| Faltering growth: recognition and management of faltering growth in children | NG75 | | |
| Psoriasis: assessment and management | CG153 | | |
| Developmental follow-up of children and young people born preterm | NG72 | | |
| Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition | CG32 | | |
| Parkinson's disease in adults | NG71 | | |
| Constipation in children and young people: diagnosis and management | CG99 | | |
| New generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scanners | HTG281 | | |
| Eliglustat for treating type 1 Gaucher disease | HST5 | | |
| Multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis | HTG441 | | |
| Spondyloarthritis in over 16s: diagnosis and management | NG65 | | |
| Idiopathic pulmonary fibrosis in adults: diagnosis and management | CG163 | | |
| Virtual chromoendoscopy to assess colorectal polyps during colonoscopy | HTG438 | | |
| Intravenous fluid therapy in adults in hospital | CG174 | | |
| Antisocial behaviour and conduct disorders in children and young people: recognition and management | CG158 | | |
| Alcohol-use disorders: diagnosis and management of physical complications | CG100 | | |
| Irritable bowel syndrome in adults: diagnosis and management | CG61 | | |
| Mental health of adults in contact with the criminal justice system | NG66 | | |
| Migalastat for treating Fabry disease | HST4 | | |
| Molecular testing strategies for Lynch syndrome in people with colorectal cancer | HTG430 | | |
| Healthcare-associated infections: prevention and control in primary and community care | CG139 | | |
| Osteoporosis: assessing the risk of fragility fracture | CG146 | | |
| Cerebral palsy in under 25s: assessment and management | NG62 | | |
| Organ donation for transplantation: improving donor identification and consent rates for deceased organ donation | CG135 | | |
| Hypothermia: prevention and management in adults having surgery | CG65 | | |
| Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis | CG95 | | |
| Spasticity in under 19s: management | CG145 | | |
| High-throughput non-invasive prenatal testing for fetal RHD genotype | HTG420 | | |
| Physical health of people in prison | NG57 | | |
| Psychosis and schizophrenia in children and young people: recognition and management | CG155 | | |
| Multimorbidity: clinical assessment and management | NG56 | | |
| Mental health problems in people with learning disabilities: prevention, assessment and management | NG54 | | |
| Stable angina: management | CG126 | | |
| Acute upper gastrointestinal bleeding in over 16s: management | CG141 | | |
| Palliative care for adults: strong opioids for pain relief | CG140 | | |
| Non-Hodgkin's lymphoma: diagnosis and management | NG52 | | |
| Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures | CG64 | | |
| Non-alcoholic fatty liver disease (NAFLD): assessment and management | NG49 | | |
| Haematological cancers: improving outcomes | NG47 | | |
| ImmunoCAP ISAC 112 for multiplex allergen testing | HTG413 | | |
| Routine preoperative tests for elective surgery | NG45 | | |
| Major trauma: service delivery | NG40 | | |
| Spinal injury: assessment and initial management | NG41 | | |
| Fractures (non-complex): assessment and management | NG38 | | |
| Major trauma: assessment and initial management | NG39 | | |
| Therapeutic monitoring of TNF-alpha inhibitors in Crohn's disease (LISA-TRACKER ELISA kits, IDKmonitor ELISA kits, and Promonitor ELISA kits) | HTG401 | | |
| Care of dying adults in the last days of life | NG31 | | |
| Children's attachment: attachment in children and young people who are adopted from care, in care or at high risk of going into care | NG26 | | |
| VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions | HTG388 | | |
| Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay) | HTG386 | | |
| Coeliac disease: recognition, assessment and management | NG20 | | |
| Lower urinary tract symptoms in men: management | CG97 | | |
| Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges | NG11 | | |
| Violence and aggression: short-term management in mental health, health and community settings | NG10 | | |
| Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes | NG5 | | |
| Bladder cancer: diagnosis and management | NG2 | | |
| Eculizumab for treating atypical haemolytic uraemic syndrome | HST1 | | |
| Fluorouracil chemotherapy: The My5‑FU assay for guiding dose adjustment | HTG360 | | |
| Gallstone disease: diagnosis and management | CG188 | | |
| Alcohol-use disorders: diagnosis, assessment and management of harmful drinking (high-risk drinking) and alcohol dependence | CG115 | | |
| Drug allergy: diagnosis and management | CG183 | | |
| Detecting, managing and monitoring haemostasis: viscoelastometric point‑of‑care testing (ROTEM, TEG and Sonoclot systems) | HTG348 | | |
| Pressure ulcers: prevention and management | CG179 | | |
| Psychosis and schizophrenia in adults: prevention and management | CG178 | | |
| Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel | HTG320 | | |
| EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer | HTG316 | | |
| Intraoperative tests (RD‑100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer | HTG315 | | |
| Varicose veins: diagnosis and management | CG168 | | |
| Social anxiety disorder: recognition, assessment and treatment | CG159 | | |
| Antisocial personality disorder: prevention and management | CG77 | | |
| Depth of anaesthesia monitors – Bispectral Index (BIS), E-Entropy and Narcotrend-Compact M | HTG292 | | |
| Neutropenic sepsis: prevention and management in people with cancer | CG151 | | |
| SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liver | HTG291 | | |
| Sickle cell disease: managing acute painful episodes in hospital | CG143 | | |
| Service user experience in adult mental health: improving the experience of care for people using adult NHS mental health services | CG136 | | |
| The EOS 2D/3D imaging system | HTG274 | | |
| Coexisting severe mental illness (psychosis) and substance misuse: assessment and management in healthcare settings | CG120 | | |
| Food allergy in under 19s: assessment and diagnosis | CG116 | | |
| Sedation in under 19s: using sedation for diagnostic and therapeutic procedures | CG112 | | |
| Bedwetting in under 19s | CG111 | | |
| Pregnancy and complex social factors: a model for service provision for pregnant women with complex social factors | CG110 | | |
| Donor milk banks: service operation | CG93 | | |
| Depression in adults with a chronic physical health problem: recognition and management | CG91 | | |
| Diarrhoea and vomiting caused by gastroenteritis in under 5s: diagnosis and management | CG84 | | |
| Rehabilitation after critical illness in adults | CG83 | | |
| Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence | CG76 | | |
| Borderline personality disorder: recognition and management | CG78 | | |
| Drug misuse in over 16s: psychosocial interventions | CG51 | | |
| Acutely ill adults in hospital: recognising and responding to deterioration | CG50 | | |
| Drug misuse in over 16s: opioid detoxification | CG52 | | |
| Faecal incontinence in adults: management | CG49 | | |
| Obsessive-compulsive disorder and body dysmorphic disorder: treatment | CG31 | | |
| Dental checks: intervals between oral health reviews | CG19 | | |